Stock listing
Indaptus Therapeutics, Inc.
Selected listing: INDP · NASDAQ · USD · US
Indaptus Therapeutics, Inc. (NASDAQ:INDP), Health Technology. Latest release Aug 13, 2026: Indaptus Therapeutics Reports Second Quarter 2026 Financial Results…
- Ticker
- NASDAQ:INDP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. is a public company traded under the ticker INDP in the American market. Indaptus focuses on developing innovative therapeutic solutions, contributing to advancements in the healthcare sector.
Latest news from Indaptus Therapeutics, Inc.
Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 13, 2026
Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 15, 2026
Indaptus Therapeutics Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
December 30, 2025
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
December 29, 2025
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
November 17, 2025
Research Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. company profile
View the public company page for Indaptus Therapeutics, Inc. on 6ix.
Indaptus Therapeutics, Inc. news
Read company news and market updates connected to Indaptus Therapeutics, Inc..
Indaptus Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Indaptus Therapeutics, Inc..